アボット・ラボラトリーズ
In September 2015, an agreement was reached with Abbott Laboratories to acquire Tendyne Holdings Inc.for a total consideration of US$400 million ($250M plus regulatory-based milestones), excluding Abbott Laboratories’ existing 10% of the company.